FDA Investigator Annet R Rajan
Annet R Rajan has inspections in 1 countries as of 26 Sep 2023. Annet R Rajan has collaborated with a combined 2155 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
15
Last Inspection Date:
26 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Addam S Reynolds,
Adetutu M Gidado,
Amber G Wardwell,
Amy C Jordan,
Amy L Singer,
Amy M Cramer,
Annemarie Bodnar,
Anthony F Lorenzo,
Anthony J Donato,
Anthony W Lee,
Antoinette L Ravelli,
Barbara Jwilimczyk Macri,
Bei Yu,
Brooke K Higgins,
Brooke K Secman,
Byungja E Marciante,
Carole L Jones,
Charlotte P Chang,
Christina P Burkhart,
Cynthia F Kleppinger, MD,
Daniel J Grabicki,
Derek S Smith, PhD,
Dhaval H Patel,
Diane T Bargo,
Diane T O'bien,
Diane T O'brien,
Doreen P Canetti,
Doreen P Gubbay,
Douglas A Campbell,
Douglas C Kovacs,
Edmund F Mrak, Jr,
Emest F Bizjak,
Emmanuel J Ramos,
Ephrem Hunde, PhD,
Erik W Koester,
Frederick Razzaghi,
Garry H Stewart,
Gerald B Seaborn, Jr,
Guerlain Ulysse,
Helen Verdel,
Hongna Wang,
James W Leonette,
James W Whitney,
Janet A Rajan,
Jean M Mulinde, MD,
Jessica Hankins, PhD,
Jessica M Monteiro,
Jessica S Estriplet,
John P Mistler,
John S Hartford,
Jonah S Ufferfilge,
Jonathan W Chapman,
Jonee J Mearns,
Jose M Cayuela,
Joy Rkozlowski Klena,
Juanita P Versace,
Junho Pak,
Justin A Boyd,
Justine Tomasso,
Karen A Briggs,
Karen A Spencer,
Kathleen M Jordan,
Kelli F Dobilas,
Kelly L Anderson,
Kenneth Nieves,
Kinh Q Mac,
Kinh Qouc Mac,
Kristy A Zielny,
Lata C Mathew, PhD,
Lauren N Barber,
Laurie B Frazier,
LCDR Debra Emerson,
Li Li,
Lori A Holmquist,
Lori S Lawless,
Malgorzata G Norton,
Marea K Harmon,
Maria Estrella,
Marion Michaelis,
Melba Trivera Clavell,
Melissa J Garcia,
Melissa T Roy,
Merideth K Rose,
Michael J Vardon,
Michael Serrano,
Mielziner,
Nancy L Rolli,
Naveen B Kanthamneni,
Nebil A Oumer,
Nicholas A Violand,
Nicole K Trudel,
Nina Yang,
Paul L Bellamy,
Peter R Lenahan,
Prabhu P Raju,
Pratibha Bhat,
Pratik S Upadhyay, DDC,
Quyen T Tran,
Rachel C Harrington,
Raymond L Cheung,
Regina Gibson Melton,
Regina T Brown,
Robert J Martin,
Robin P Mathew,
Russell J Glapion,
Saleem A Akhtar,
Sean R Marcsisin,
Sena G Dissmeyer,
Shirley S Wen,
Sony Mathews,
Stacey S Degarmo,
Stelios C Tsinontides,
Steven P Donald,
Tania E Vizcaino,
Tanya R Syffrard,
Tonia F Bernard,
Toyin B Oladimeji,
Vivin George,
Walter Fava,
Walter L Fava,
William A Warnick,
William H Linkroum,
Yvins Dezan,
Zakaria I Ganiyu
Annet R Rajan's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2020 | EIR | Eywa Pharma Inc. - EIR, 2020-09-08 |
February, 2022 | FDA 483 | Aspire Pharmaceuticals Inc. - Form 483, 2022-02-03 |
May, 2021 | FDA 483 | HOVIONE LLC - Form 483, 2021-05-28 |
September, 2020 | FDA 483 | Eywa Pharma Inc. - Form 483, 2020-09-08 |
November, 2022 | EIR | PDA Laboratories, Inc. - EIR, 2022-11-15 |
May, 2021 | FDA 483 Response | HOVIONE LLC - Form 483R, 2022-02-18 |
September, 2021 | FDA 483 Response | Tender Corporation - Form 483R, 2021-10-15 |
October, 2022 | FDA 483 | QuVa Pharma, Inc. - Form 483, 2022-10-14 |
September, 2021 | FDA 483 | Tender Corporation - Form 483, 2021-09-23 |
December, 2022 | FDA 483 | FISHER SCIENTIFIC CHEMICAL DIVISION - Form 483, 2022-12-16 |
July, 2023 | FDA 483 | Aspire Pharmaceuticals Inc. - Form 483, 2023-07-14 |
February, 2023 | FDA 483 | Evergreen Theragnostics, Inc. - Form 483, 2023-02-23 |
March, 2022 | FDA 483 | ImmuCell Corporation - Form 483, 2022-03-29 |
July, 2021 | FDA 483 | Novitium Pharma LLC - Form 483, 2021-07-08 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more